Skip to main content

Table 3 Relative effect of Robust MANOVA

From: Risk factors for Candida parapsilosis bloodstream infection in a neonatal intensive care unit: a case-control study

Group Duration of use of CVC Duration of use of UC Duration of use of AV Gestational Age Birth Weight
1 0.167 0.186 0.720 0.745 0.877
2 0.479 0.394 0.531 0.494 0.490
3 0.395 0.384 0.559 0.540 0.488
4 0.555 0.548 0.567 0.608 0.531
5 0.501 0.514 0.428 0.575 0.462
6 0.515 0.527 0.483 0.488 0.534
7 0.443 0.424 0.539 0.428 0.523
8 0.549 0.518 0.471 0.426 0.409
9 0.552 0.568 0.426 0.424 0.450
10 0.543 0.547 0.464 0.504 0.559